Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Iron in Iron Deficient IPAH
NCT01288651Phase 4Unknown
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Amsterdam University Medical Center. Primary endpoint: Six-Minute Walking Distance at 12 weeks. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01288651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01288651.